ACADIA Pharmaceuticals, Inc. (ACAD)
21.48
-0.87
(-3.89%)
USD |
NASDAQ |
May 06, 16:00
21.00
-0.48
(-2.23%)
After-Hours: 07:06
ACADIA Pharmaceuticals Cash from Investing (Quarterly) : -55.87M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Insmed, Inc. | 389.41M |
| Madrigal Pharmaceuticals, Inc. | 192.19M |
| Merck & Co., Inc. | -10.21B |
| BioMarin Pharmaceutical, Inc. | 725.53M |
| Regeneron Pharmaceuticals, Inc. | -428.90M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -48.73M |
| Cash from Financing (Quarterly) | 22.67M |
| Free Cash Flow | 6.308M |
| Free Cash Flow Per Share (Quarterly) | -0.3078 |
| Free Cash Flow to Equity (Quarterly) | -50.11M |
| Free Cash Flow to Firm (Quarterly) | -52.74M |
| Free Cash Flow Yield | 0.17% |